前列腺特异性膜抗原PET/CT偶然发现急性淋巴细胞白血病
一名前列腺癌分期患者(Gleason 3+4,PSA 5.8)行PSMA PET/CT,显示弥漫性骨髓PSMA摄取,不符合典型前列腺癌转移表现。血清学和骨髓活检证实为B细胞急性淋巴细胞白血病,右侧坐骨局灶性PSMA摄取与既往MRI T1低信号病灶相关,考虑为骨转移。因此,弥漫性骨骼PSMA摄取需考虑其他诊断。
要点
- PSMA PET/CT弥漫性骨髓摄取需鉴别白血病等非前列腺癌病变。
- 局灶性PSMA摄取结合MRI可提示骨转移。
- 前列腺癌分期中偶然发现异常摄取应结合血清学和活检。
核心结论
- PSMA PET/CT弥漫性骨骼摄取不一定为前列腺癌转移,需考虑急性淋巴细胞白血病等替代诊断。
研究设计与样本
- 本文为病例报告,描述一例前列腺癌分期患者行PSMA PET/CT的偶然发现。
主要发现
- PSMA PET/CT显示弥漫性骨髓PSMA摄取,不典型于前列腺癌转移,当时未开始治疗。
- 血清学和骨髓活检显示B细胞急性淋巴细胞白血病。
- 右侧坐骨局灶性PSMA摄取与既往MRI T1低信号病灶相关, convincing for skeletal metastasis。
关键数值与推荐
- 前列腺癌分期患者Gleason 3+4左尖,PSA 5.8。
临床怎么用
- 对于PSMA PET/CT弥漫性骨骼摄取,应结合临床和实验室检查考虑白血病等鉴别诊断。
局限性
- 本文为单例病例报告,结论推广受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PSMA PET/CT is known to show uptake in various benign and malignant processes. The following PSMA PET/CT was performed for prostate carcinoma staging (Gleason 3 + 4 left apex; PSA 5.8). It shows incidental diffuse PSMA marrow uptake, not typical for prostate metastatic disease. No treatment had been commenced at the time of the scan. Serology and bone marrow biopsy showed B-cell acute lymphocytic leukemia. Focal PSMA uptake in the right ischium was correlated with a T1 hypointense lesion on a previous MRI and was convincing for a skeletal metastasis. Alternative diagnoses in diffuse skeletal PSMA uptake need therefore to be considered.
引用
- Acksteiner C, Sounness B. Incidental Finding of Acute Lymphocytic Leukemia in a Prostate-Specific Membrane Antigen PET/CT. Clin Nucl Med. 2019. PMID: 31306192. doi:10.1097/RLU.0000000000002712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。